Scientists test new Drug's hidden interactions
NCT ID NCT06813924
Summary
This study tested whether a new drug being developed for sickle cell disease and thalassemia, called etavopivat, changes how the body processes five other common medications. Healthy adult volunteers took etavopivat along with single doses of digoxin, rosuvastatin, midazolam, pitavastatin, and metformin. The goal was to measure drug levels in the blood to see if etavopivat made these other drugs stronger, weaker, or last longer in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON-Salt Lake City
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.